These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 38782965)
1. FAT1 inhibits the proliferation of DLBCL cells via increasing the m Wang TL; Miao XJ; Shuai YR; Sun HP; Wang X; Yang M; Zhang N Sci Rep; 2024 May; 14(1):11836. PubMed ID: 38782965 [TBL] [Abstract][Full Text] [Related]
2. GPNMB promotes the progression of diffuse large B cell lymphoma via YAP1-mediated activation of the Wnt/β-catenin signaling pathway. Wang Z; Ran X; Qian S; Hou H; Dong M; Wu S; Ding M; Zhang Y; Zhang X; Zhang M; Chen Q Arch Biochem Biophys; 2021 Oct; 710():108998. PubMed ID: 34280359 [TBL] [Abstract][Full Text] [Related]
3. N6-methyladenosine-modified circTEAD1 stabilizes Yap1 mRNA to promote chordoma tumorigenesis. Li H; Tang Y; Ruan X; Zhang J; Liu H; Yu S; Chen H; Yang H; Zhang K; Chen K Clin Transl Med; 2024 Apr; 14(4):e1658. PubMed ID: 38659080 [TBL] [Abstract][Full Text] [Related]
4. Knockdown of YAP1 Reduces YTHDF3 to Stabilize Qiu D; Gao L; Yu X Discov Med; 2024 Jul; 36(186):1486-1498. PubMed ID: 39054719 [TBL] [Abstract][Full Text] [Related]
5. m Jin D; Guo J; Wu Y; Yang L; Wang X; Du J; Dai J; Chen W; Gong K; Miao S; Li X; Sun H Mol Cancer; 2020 Feb; 19(1):40. PubMed ID: 32106857 [TBL] [Abstract][Full Text] [Related]
6. FAT1 inhibits AML autophagy and proliferation via downregulating ATG4B expression. Zhang N; Shen MY; Meng QL; Sun HP; Fan FY; Yi H; Yang YJ Biochim Biophys Acta Gen Subj; 2024 Jan; 1868(1):130519. PubMed ID: 37952564 [TBL] [Abstract][Full Text] [Related]
7. MiR-665 suppresses the progression of diffuse large B cell lymphoma (DLBCL) through targeting LIM and SH3 protein 1 (LASP1). Wang Y; Guo D; Li B; Wang Y; Wang B; Wang Z; Wang M; Teng Q Leuk Res; 2022 Jan; 112():106769. PubMed ID: 34875555 [TBL] [Abstract][Full Text] [Related]
8. m Jin D; Guo J; Wu Y; Du J; Yang L; Wang X; Di W; Hu B; An J; Kong L; Pan L; Su G J Hematol Oncol; 2019 Dec; 12(1):135. PubMed ID: 31818312 [TBL] [Abstract][Full Text] [Related]
9. KIAA1429-mediated m6A modification of CHST11 promotes progression of diffuse large B-cell lymphoma by regulating Hippo-YAP pathway. Chen X; Lu T; Cai Y; Han Y; Ding M; Chu Y; Zhou X; Wang X Cell Mol Biol Lett; 2023 Apr; 28(1):32. PubMed ID: 37076815 [TBL] [Abstract][Full Text] [Related]
10. PKC Regulates YAP Expression through Alternative Splicing of YAP 3'UTR Pre-mRNA by hnRNP F. Chu WK; Hung LM; Hou CW; Chen JK Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33445676 [TBL] [Abstract][Full Text] [Related]
12. Activation of YAP1 by N6-Methyladenosine-Modified circCPSF6 Drives Malignancy in Hepatocellular Carcinoma. Chen Y; Ling Z; Cai X; Xu Y; Lv Z; Man D; Ge J; Yu C; Zhang D; Zhang Y; Xie H; Zhou L; Wu J; Zheng S Cancer Res; 2022 Feb; 82(4):599-614. PubMed ID: 34916222 [TBL] [Abstract][Full Text] [Related]
13. miR-183-5p overexpression orchestrates collective invasion in salivary adenoid cystic carcinoma through the FAT1/YAP1 signaling pathway. Chen BJ; Jiang J; Li T; Jiang HJ; Liang XH; Tang YL Biochem Biophys Res Commun; 2023 May; 655():127-137. PubMed ID: 36934588 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-26a/cyclin-dependent kinase 5 axis controls proliferation, apoptosis and in vivo tumor growth of diffuse large B-cell lymphoma cell lines. Farina FM; Inguscio A; Kunderfranco P; Cortesi A; Elia L; Quintavalle M Cell Death Dis; 2017 Jun; 8(6):e2890. PubMed ID: 28640256 [TBL] [Abstract][Full Text] [Related]
15. Fat1 deletion promotes hybrid EMT state, tumour stemness and metastasis. Pastushenko I; Mauri F; Song Y; de Cock F; Meeusen B; Swedlund B; Impens F; Van Haver D; Opitz M; Thery M; Bareche Y; Lapouge G; Vermeersch M; Van Eycke YR; Balsat C; Decaestecker C; Sokolow Y; Hassid S; Perez-Bustillo A; Agreda-Moreno B; Rios-Buceta L; Jaen P; Redondo P; Sieira-Gil R; Millan-Cayetano JF; Sanmatrtin O; D'Haene N; Moers V; Rozzi M; Blondeau J; Lemaire S; Scozzaro S; Janssens V; De Troya M; Dubois C; Pérez-Morga D; Salmon I; Sotiriou C; Helmbacher F; Blanpain C Nature; 2021 Jan; 589(7842):448-455. PubMed ID: 33328637 [TBL] [Abstract][Full Text] [Related]
16. RNA m6A methylation promotes the formation of vasculogenic mimicry in hepatocellular carcinoma via Hippo pathway. Qiao K; Liu Y; Xu Z; Zhang H; Zhang H; Zhang C; Chang Z; Lu X; Li Z; Luo C; Liu Y; Yang C; Sun T Angiogenesis; 2021 Feb; 24(1):83-96. PubMed ID: 32920668 [TBL] [Abstract][Full Text] [Related]
17. ABCG2 is a direct transcriptional target of hedgehog signaling and involved in stroma-induced drug tolerance in diffuse large B-cell lymphoma. Singh RR; Kunkalla K; Qu C; Schlette E; Neelapu SS; Samaniego F; Vega F Oncogene; 2011 Dec; 30(49):4874-86. PubMed ID: 21625222 [TBL] [Abstract][Full Text] [Related]
18. Regulation of Hippo-YAP signaling by insulin-like growth factor-1 receptor in the tumorigenesis of diffuse large B-cell lymphoma. Zhou X; Chen N; Xu H; Zhou X; Wang J; Fang X; Zhang Y; Li Y; Yang J; Wang X J Hematol Oncol; 2020 Jun; 13(1):77. PubMed ID: 32546241 [TBL] [Abstract][Full Text] [Related]
19. N6-methyladenosine modification of LATS2 promotes hepatoblastoma progression by inhibiting ferroptosis through the YAP1/ATF4/PSAT1 axis. Zhu G; Xie Y; Bian Z; Ma J; Zhen N; Chen T; Zhu J; Mao S; Tang X; Liu L; Gu S; Ding M; Pan Q Int J Biol Sci; 2024; 20(11):4146-4161. PubMed ID: 39247829 [TBL] [Abstract][Full Text] [Related]